These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
640 related articles for article (PubMed ID: 23582684)
1. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684 [TBL] [Abstract][Full Text] [Related]
2. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707 [TBL] [Abstract][Full Text] [Related]
3. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530 [TBL] [Abstract][Full Text] [Related]
4. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas. Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520 [TBL] [Abstract][Full Text] [Related]
5. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy. Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009 [TBL] [Abstract][Full Text] [Related]
6. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434 [TBL] [Abstract][Full Text] [Related]
7. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
8. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628 [TBL] [Abstract][Full Text] [Related]
9. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates. Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394 [TBL] [Abstract][Full Text] [Related]
10. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889 [TBL] [Abstract][Full Text] [Related]
11. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528 [TBL] [Abstract][Full Text] [Related]
12. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment. Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868 [TBL] [Abstract][Full Text] [Related]
15. UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma. Zhang B; Zhang Y; Liao Z; Jiang T; Zhao J; Tuo Y; She X; Shen S; Chen J; Zhang Q; Jiang X; Hu Y; Pang Z Biomaterials; 2015 Jan; 36():98-109. PubMed ID: 25443789 [TBL] [Abstract][Full Text] [Related]
16. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels. Hu Q; Gao X; Kang T; Feng X; Jiang D; Tu Y; Song Q; Yao L; Jiang X; Chen H; Chen J Biomaterials; 2013 Dec; 34(37):9496-508. PubMed ID: 24054848 [TBL] [Abstract][Full Text] [Related]
17. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
18. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy. Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590 [TBL] [Abstract][Full Text] [Related]
19. iRGD-mediated core-shell nanoparticles loading carmustine and O Liu C; Yao S; Li X; Wang F; Jiang Y J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474 [TBL] [Abstract][Full Text] [Related]
20. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier. Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]